Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Design
  4. Volume 30, Issue 13
  5. Article
Volume 30, Issue 13
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The popular perennial creeping plant known as (also known as Brahmi) is being utilized in the Indian Ayurvedic medicine practice. It has a variety of bioactive phytoconstituents that have been used therapeutically to treat a number of serious illnesses. Ancient Vedic scholars used this herb because of its pharmacological effects, particularly as a nerve booster and nootropic supporter. However, it is vital to comprehend the active phytochemical components of extract (BME) and their molecular mechanisms in order to better grasp the effect of BME on neurological illnesses and diseases. Understanding its active phytochemical constituents and their molecular processes is essential. Numerous clinical investigations indicated that BME may have neuroprotective benefits, so it is worthwhile to re-evaluate this well-known plant. Here, we focused on neurological problems as we examined the pharmacological and phytochemical characteristics of BME. For their effective usage in neuroprotection and cognition, many clinical concerns and the synergistic potential of Bacopa extract have been investigated. Alzheimer’s disease is a neurological condition caused by the production of reactive oxygen species, which also causes amyloid-beta (Aβ) and tau protein aggregation and increases neuro-inflammation and neurotoxicity. Our review offers a more in-depth molecular understanding of the neuroprotective functions of BME, which can also be connected to its therapeutic management of neurological illnesses and cognitive-improving effects.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128288698240305094945
2024-04-01
2024-11-14

  • From This Site

    /content/journals/cpd/10.2174/0113816128288698240305094945
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZhangX. WHO Traditional Medicine Strategy 2002-2005.2002Available from: https://www.iso.org/standard/70958.html
  2. DarokarM.P. KhanujaS.P.S. Kumar ShasanyA. KumarS. Low levels of genetic diversity detected by RAPD analysis in geographically distinct accessions of Bacopa monnieri.Genet. Resour. Crop Evol.200148655555810.1023/A:1013800101604
     [Google Scholar]
  3. JoshiH. ParleM. Brahmi rasayana improves learning and memory in mice.Evid. Based Complement. Alternat. Med.200631798510.1093/ecam/nek01416550227
     [Google Scholar]
  4. SinghH. RaghavS. DalalP.K. SrivastavaJ.S. AsthanaO.P. Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment.Indian J. Psychiatry200648423824210.4103/0019‑5545.3155520703343
     [Google Scholar]
  5. PhrompittayaratW. PutalunW. TanakaH. JetiyanonK. Wittaya-AreekulS. IngkaninanK. Comparison of various extraction methods of Bacopa monnieri.NUJST2013152934
     [Google Scholar]
  6. BhattacharyaS.K. BhattacharyaA. KumarA. GhosalS. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus.Phytother. Res.200014317417910.1002/(SICI)1099‑1573(200005)14:3<174::AID‑PTR624>3.0.CO;2‑O10815010
     [Google Scholar]
  7. JyotiA. SharmaD. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain.Neurotoxicology200627445145710.1016/j.neuro.2005.12.00716500707
     [Google Scholar]
  8. RussoA. BorrelliF. Bacopa monniera, a reputed nootropic plant: an overview.Phytomedicine200512430531710.1016/j.phymed.2003.12.00815898709
     [Google Scholar]
  9. MurthyP.B.S. RajuV.R. RamakrisanaT. Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography.Chem. Pharm. Bull.200654690791110.1248/cpb.54.90716755069
     [Google Scholar]
  10. GudipatiT. SrivastavaP. BhadauriaR. PrasadG. Hepatoprotective potential of in vitro Bacopa monnieri (L.) against carbon tetrachloride-induced hepatotoxicity in albino mice.Int. J. Pharm. Biol. Sci.20123664672
     [Google Scholar]
  11. GudipatiT. SrivastavaP. GoswamiH. BhadauriaR. In vitro conservation of Bacopa monnieri germplasm: A critically endangered medicinal plant of madhya pradesh.J. Indian Bot. Soc.2012918391
     [Google Scholar]
  12. NegiK. SinghY. KushwahaK. Clinical evaluation of memory enhancing properties of memory plus in children with attention deficit hyperactivity disorder.Indian J. Psychiatry2000424
     [Google Scholar]
  13. BihareeA. ChaudhariL. BhartiyaS. A comprehensive study on natural products and their bioactive constituents to cure respiratory diseases.Nat. Prod. J.2024142e12062321787910.2174/2210315513666230612111133
     [Google Scholar]
  14. TruptiP. AditiC. KajalK. NameerahR. RakheN. ShaikhK.A. Ayurvedic remedies of tuberculosis.World J Adv Res Rev202111328029010.30574/wjarr.2021.11.3.0466
     [Google Scholar]
  15. MakhaikM. S. ShakyaA. K. KaleR. Dietary phytochemicals: As a natural source of antioxidants. In:Antioxidants - Benefits, Sources, Mechanisms of Action. IntechOpen2021
     [Google Scholar]
  16. HusainA. KaushikA. AwasthiH. SinghD.P. KhanR. ManiD. Immunomodulatory and antioxidant activities of fresh juice extracts of Brahmi and Guduchi.Indian J. Tradit. Knowl.201716498505
     [Google Scholar]
  17. BairyK. Wound healing potentials of plant products.J. Nat. Rem.200221120
     [Google Scholar]
  18. MondalS. BharK. MondalP. In quest of the mysterious holistic vedic herb Bacopa monnieri (L.) Pennell.Pharmacognosy Res.202315341045410.5530/pres.15.3.045
     [Google Scholar]
  19. RamadasD. RavishankarM. ShwethaS. ChikkannaD. Phytochemical studies and antioxidant activity of Bacopa monnieri plant leaves proteins.Indo Am J Pharm Res2016643024307
     [Google Scholar]
  20. SivaramakrishnaC. RaoC.V. TrimurtuluG. VanisreeM. SubbarajuG.V. Triterpenoid glycosides from Bacopa monnieri.Phytochemistry200566232719272810.1016/j.phytochem.2005.09.01616293276
     [Google Scholar]
  21. BhandariP. KumarN. SinghB. KaulV.K. Bacosterol glycoside, a new 13,14-seco-steroid glycoside from Bacopa monnieri.Chem. Pharm. Bull.200654224024110.1248/cpb.54.24016462073
     [Google Scholar]
  22. JeyasriR. MuthuramalingamP. SubaV. RameshM. ChenJ.T. Bacopa monnieri and their bioactive compounds inferred multi-target treatment strategy for neurological diseases: A cheminformatics and system pharmacology approach.Biomolecules202010453610.3390/biom1004053632252235
     [Google Scholar]
  23. JeyasriR. MuthuramalingamP. AdarshanS. ShinH. RameshM. Assessing the anti-inflammatory effects of bacopa-derived bioactive compounds using network pharmacology and in vitro studies.ACS Omega2022744403444035410.1021/acsomega.2c0531836385888
     [Google Scholar]
  24. YaribeygiH. PanahiY. JavadiB. SahebkarA. The underlying role of oxidative stress in neurodegeneration: A mechanistic review.CNS Neurol. Disord. Drug Targets201817207215
     [Google Scholar]
  25. RehmanM.U. SeharN. DarN.J. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments.Neurosci. Biobehav. Rev.202314410496110.1016/j.neubiorev.2022.10496136395982
     [Google Scholar]
  26. HagueS.M. KlaffkeS. BandmannO. Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease.J. Neurol. Neurosurg. Psychiatry20057681058106310.1136/jnnp.2004.06018616024878
     [Google Scholar]
  27. TrojanowskiJ.Q. LeeV.M. “Fatal attractions” of proteins. A comprehensive hypothetical mechanism underlying Alzheimer’s disease and other neurodegenerative disorders.Ann. N. Y. Acad. Sci.20009241626710.1111/j.1749‑6632.2000.tb05561.x11193803
     [Google Scholar]
  28. JennekensF.G.I. A short history of the notion of neurodegenerative disease.J. Hist. Neurosci.2014231859410.1080/0964704X.2013.80929724512132
     [Google Scholar]
  29. RadunovicA. AnnaneD. RafiqM.K. BrassingtonR. MustfaN. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Libr.201720186CD00442710.1002/14651858.CD004427.pub428982219
     [Google Scholar]
  30. Sharifi-RadM. LankatillakeC. DiasD.A. Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics.J. Clin. Med.202094106110.3390/jcm904106132276438
     [Google Scholar]
  31. HussainG. RasulA. AnwarH. Role of plant derived alkaloids and their mechanism in neurodegenerative disorders.Int. J. Biol. Sci.201814334135710.7150/ijbs.2324729559851
     [Google Scholar]
  32. SinghK. YadavD. ChauhanP.S. MishraM. JinJ.O. Novel therapeutics for the treatment of Alzheimer’s and Parkinson’s disease.Curr. Pharm. Des.202026775576310.2174/138161282666620010716105131914906
     [Google Scholar]
  33. ChauhanP. S. YadavD. ArukhaA. P. Dietary nutrients and prevention of Alzheimer’s disease.CNS Neurol. Disord. Drug Targets202221217227
     [Google Scholar]
  34. KoulB. FarooqU. YadavD. SongM. Phytochemicals: A promising alternative for the prevention of Alzheimer’s disease.Life202313499910.3390/life1304099937109528
     [Google Scholar]
  35. ChauhanP.S. YadavD. KoulB. MohantaY.K. JinJ.O. Recent advances in nanotechnology: A novel therapeutic system for the treatment of Alzheimer’s disease.Curr. Drug Metab.202021141144115110.2174/138920022166620112414051833234100
     [Google Scholar]
  36. ShankarP.S. PreetiB. SantanuB. GajananD. RupeshD. Brahmi (Bacopa monnieri) as functional food ingredient in food processing industry.J. Pharmacogn. Phytochem.20187189194
     [Google Scholar]
  37. OtariS.S. DevkarS.P. PatelS.B. GhaneS.G. Micropropagation and elicited production of triterpenoid saponin glycosides and stigmasterol via precursor and elicitor feeding in Bacopa floribunda (R.Br.) Wettst-A potential nootropic herb.Front Plant Sci202314109684210.3389/fpls.2023.109684236798714
     [Google Scholar]
  38. FatimaU. RoyS. AhmadS. Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation.Front. Nutr.2022997237910.3389/fnut.2022.97237936061899
     [Google Scholar]
  39. KumariA. KumarA. MandalS. RoyP. SircarD. A metabolic reprogramming in Bacopa monnieri plants induced by methyl-jasmonate and enhanced biosynthesis of triterpene saponins.Ind. Crops Prod.202320411724110.1016/j.indcrop.2023.117241
     [Google Scholar]
  40. SaesongT. AllardP-M. QueirozE.F. Discovery of lipid peroxidation inhibitors from Bacopa species prioritized through multivariate data analysis and multi-informative molecular networking.Molecules20192416298910.3390/molecules2416298931426532
     [Google Scholar]
  41. GiramkarS.A. KulkarniO.P. JagtapS.D. Anticonvulsant potential of commonly practiced formulations of Brahmi (Bacopa monnieri Linn.) in Wistar rats.J. Pharm. Res.20137978779110.1016/j.jopr.2013.09.008
     [Google Scholar]
  42. KhanM.B. AhmadM. AhmadS. Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences.Metab. Brain Dis.201530111512710.1007/s11011‑014‑9593‑525037167
     [Google Scholar]
  43. DhanasekaranM. TharakanB. HolcombL.A. HittA.R. YoungK.A. ManyamB.V. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera.Phytother. Res.2007211096596910.1002/ptr.219517604373
     [Google Scholar]
  44. MathewJ. BalakrishnanS. AntonyS. AbrahamP.M. PauloseC.S. Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A.J. Biomed. Sci.20121912510.1186/1423‑0127‑19‑2522364254
     [Google Scholar]
  45. HaslerG. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians?World Psychiatry20109315516110.1002/j.2051‑5545.2010.tb00298.x20975857
     [Google Scholar]
  46. CraftL.L. PernaF.M. The benefits of exercise for the clinically depressed.Prim. Care Companion J. Clin. Psychiatry20046310411115361924
     [Google Scholar]
  47. MoncrieffJ. CooperR.E. StockmannT. AmendolaS. HengartnerM.P. HorowitzM.A. The serotonin theory of depression: A systematic umbrella review of the evidence.Mol. Psychiatry20232883243325610.1038/s41380‑022‑01661‑035854107
     [Google Scholar]
  48. SairamK. DorababuM. GoelR.K. BhattacharyaS.K. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats.Phytomedicine20029320721110.1078/0944‑7113‑0011612046860
     [Google Scholar]
  49. HazraS. BanerjeeR. DasB.K. Evaluation of antidepressant activity of Bacopa monnieri in rat: A study in animal model of depression.Drug Discov20122813
     [Google Scholar]
  50. RaiD. BhatiaG. PalitG. PalR. SinghS. SinghH.K. Adaptogenic effect of Bacopa monniera (Brahmi).Pharmacol. Biochem. Behav.200375482383010.1016/S0091‑3057(03)00156‑412957224
     [Google Scholar]
  51. ShahidM. SubhanF. UllahI. AliG. AlamJ. ShahR. Beneficial effects of Bacopa monnieri extract on opioid induced toxicity.Heliyon201622e0006810.1016/j.heliyon.2016.e0006827441247
     [Google Scholar]
  52. AkramM. NawazA. Effects of medicinal plants on Alzheimer’s disease and memory deficits.Neural Regen. Res.201712466067010.4103/1673‑5374.20510828553349
     [Google Scholar]
  53. GoldC.A. BudsonA.E. Memory loss in Alzheimer’s disease: Implications for development of therapeutics.Expert Rev. Neurother.20088121879189110.1586/14737175.8.12.187919086882
     [Google Scholar]
  54. SinghalA. BangarO.P. NaithaniV. Medicinal plants with a potential to treat Alzheimer and associated symptoms.Int. J. Nutr. Pharmacol. Neurol. Dis.201222849110.4103/2231‑0738.95927
     [Google Scholar]
  55. GlabeC. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease.J. Mol. Neurosci.200117213714510.1385/JMN:17:2:13711816787
     [Google Scholar]
  56. TakahashiR.H. NagaoT. GourasG.K. Plaque formation and the intraneuronal accumulation of β‐amyloid in Alzheimer’s disease.Pathol. Int.201767418519310.1111/pin.1252028261941
     [Google Scholar]
  57. LiguoriI. RussoG. CurcioF. Oxidative stress, aging, and diseases.Clin. Interv. Aging20181375777210.2147/CIA.S15851329731617
     [Google Scholar]
  58. MalishevR. Shaham-NivS. NandiS. KolushevaS. GazitE. JelinekR. Bacoside-A, an Indian traditional-medicine substance, inhibits β-amyloid cytotoxicity, fibrillation, and membrane interactions.ACS Chem. Neurosci.20178488489110.1021/acschemneuro.6b0043828094495
     [Google Scholar]
  59. GoldeT.E. SchneiderL.S. KooE.H. Anti-aβ therapeutics in Alzheimer’s disease: The need for a paradigm shift.Neuron201169220321310.1016/j.neuron.2011.01.00221262461
     [Google Scholar]
  60. Abdul ManapA.S. VijayabalanS. MadhavanP. Bacopa monnieri, a neuroprotective lead in Alzheimer disease: A review on its properties, mechanisms of action, and preclinical and clinical studies.Drug Target Insights201913117739281986641210.1177/117739281986641231391778
     [Google Scholar]
  61. WiatrakB. JawieńP. MatuszewskaA. SzelągA. Kubis-KubiakA. Effect of amyloid-β on the redox system activity in SH-SY5Y cells preincubated with lipopolysaccharide or co-cultured with microglia cells.Biomed. Pharmacother.202214911288010.1016/j.biopha.2022.11288035367762
     [Google Scholar]
  62. GoswamiS. SaojiA. KumarN. ThawaniV. TiwariM. ThawaniM. Effect of Bacopa monnieri on cognitive functions in Alzheimer’s disease patients.Int J Collaborat Res Int Med Public Health20113285293
     [Google Scholar]
  63. KunteK.B. KunaY. Neuroprotective effect of Bacopa monniera on memory deficits and ATPase system in Alzheimer’s disease (AD) induced mice.J Sci Innov Res20132719735
     [Google Scholar]
  64. UabunditN. WattanathornJ. MucimapuraS. IngkaninanK. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model.J. Ethnopharmacol.20101271263110.1016/j.jep.2009.09.05619808086
     [Google Scholar]
  65. MorganA. StevensJ. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial.J. Altern. Complement. Med.201016775375910.1089/acm.2009.034220590480
     [Google Scholar]
  66. McPheeG.M. DowneyL.A. WesnesK.A. StoughC. The neurocognitive effects of Bacopa monnieri and cognitive training on markers of brain microstructure in healthy older adults.Front. Aging Neurosci.20211363810910.3389/fnagi.2021.63810933692683
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128288698240305094945
Loading
Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases
Curr. Pharm. Des. 30, 1016 (2024); https://doi.org/10.2174/0113816128288698240305094945
/content/journals/cpd/10.2174/0113816128288698240305094945
/content/journals/cpd/10.2174/0113816128288698240305094945
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Alzheimer’s disease; amyloid-beta; Bacopa monnieri extract; neuroprotective; Parkinson's disease; tau protein

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test